Dr. Devon 是一名生物学家，致力于神经系统科学和遗传学。她于1996年取得了精神疾病遗传学的博士学位。随后在加拿大温哥华以及英国的爱丁堡开始了博士后的深造，主要研究运动神经元疾病 (Lou Gehrig's Disease，洛盖赫里格病 ) 的一种罕见遗传形式。她著有50余篇研究论文、专书论文、评论和经费申请，曾为分子生物学期刊审稿。Dr. Devon 从2008年起为理文编辑工作。

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

Featured Editor

Immunology, physiology, anatomy and oncology specialist

Dr Cooke拥有免疫学专业背景，重点研究人体对器官移植的免疫反应。博士学位的主要研究领域是新发现的猪内皮细胞异种抗原的功能意义。曾在关节炎和风湿病理事会（ARC）和英国癌症研究学院（CRUK）任博士后研究员，主攻领域是针对癌细胞将基于抗体融合蛋白工程作为全新治疗手段。专长于酶联免疫吸附试验（ELISA）的设计与使用，PCR和RT – PCR，原代细胞培养，细胞毒性实验，DNA提取、纯化、测序和克隆，高效液相色谱，放射性标记技术、抗原抗体相互作用动力学分析，抗体分离与提纯，以及噬菌体展示技术的使用等。Dr Cooke还是有资质的理疗师，具有人体解剖学和生理学的广博知识。于2009年开始为理文编辑工作。

Dr Cooke’s scientific background is in immunology, with an emphasis on human immune responses to organ transplants. His PhD focused on the functional significance of newly identified xenoantigens expressed by porcine endothelial cells. He has worked as a post-doctoral fellow for both the Arthritis and Rheumatism Council (ARC) and Cancer Research UK (CRUK). The main focus of his post-doctoral work was the engineering of antibody-based fusion proteins specifically targeted to cancer cells, as a novel from of therapy. Dr Cooke has technical expertise in the design and use of enzyme-linked immunosorbent assay (ELISA), PCR and RT-PCR, primary cell culture, cellular cytotoxicity assays, DNA isolation, purification, sequencing and cloning, HPLC, radiolabelling techniques, kinetic analysis of antibody–antigen interactions, antibody isolation and purification and the use of phage display technology. He is also a qualified physiotherapist with extensive knowledge of human anatomy and physiology. Dr Cooke began working with the Edanz Group in 2009.

Featured Editor

Formerly a specialist Medical Indexer at Thomson Scientific

Dr Furness在格拉斯哥Beatson癌症研究院从事三年的博士后研究，此期间，利用分子遗传学技术对与癌症（如白血病）发展有关、影响造血干细胞生长的因素进行研究。后任格拉斯哥大学研究员，通过实地观察、放射同位素血液样分析和对海鸟代谢监测，分析海鸟的能量需求。Dr Furness是一位知识渊博的科技编辑，拥有大量的科技论文提炼、索引和编辑经验，涉及的领域包括通用医学、药学和遗传学，在科研实践和发表研究论文方面拥有丰富的个人经历。1993-2007年期间，在Thomson Scientific从事专家医学文摘工作，2007年起为理文编辑工作。

For three years, Dr Furness was a Post-doctoral Research Fellow at the Beatson Institute for Cancer Research, Glasgow, where she used extensive molecular genetic techniques to examine the factors influencing the growth of hematopoietic stem cells, with relevance to the development of cancers such as leukemia. Later Dr Furness was a researcher at Glasgow University where she analyzed the energetic requirements of seabirds, using field observations, analysis of radioisotopes from blood samples and metabolic monitoring of birds in respirometers. Dr Furness is a scientific editor with extensive experience of abstracting, indexing and editing scientific papers on a wide range of topics including general medicine, pharmacology and genetics, with personal experience of active scientific research and the publishing of research papers. From 1993 to 2007, Dr Furness was a Specialist Medical Indexer at Thomson Scientific. She began working with Edanz Editing in 2007.

Dr. Rider是英国剑桥的一位研究科学家，目前在一家跨国制药公司致力于呼吸系统疾病和炎症的生物疗法。他的博士阶段是研究在类风湿性关节炎发病中T细胞炎症微环境所起到的作用。Dr. Rider的博士后阶段在英国和新加坡度过，致力于多种细胞生物学和免疫学科目的研究，包括间叶细胞和造血干细胞。他已在国际同行审阅期刊上发表过10篇文章，并且在多个国际会议上介绍过自己的研究成果。Dr. Rider于2009年开始为理文编辑工作。

Dr Rider is a research scientist resident in Cambridge, United Kingdom, where he is involved in developing biological therapeutics for respiratory and inflammatory diseases for a multinational pharmaceutical company. For his PhD, he investigated the role of the inflammatory microenvironment on T cell function in rheumatoid arthritis. Dr Rider was a post-doctoral fellow in the UK and Singapore, studying a diverse range of cell biology and immunology topics, including mesenchymal and hematopoietic stem cells. He has published 10 papers in international peer-reviewed journals, and presented his research at several international conferences. Dr Rider began editing for the Edanz Group in 2009.

Featured Editor

PhD in microbiology from the University of Oxford

Dr Fox拥有牛津大学微生物学博士学位，攻读博士学位期间主要研究流感嗜血杆菌生物合成基因中的新型相变脂多糖。此后，在澳大利亚昆士兰大学从事5年博士后研究，重点研究DNA甲基转移酶在细菌病原体基因调节中的作用，其他项目包括：兽医病原体活性减毒疫苗的设计与开发。以第一作者的身份在微生物病原领域的高级期刊杂志上发表了多篇文章。现为一名全职编辑，拥有广泛的生物学科经验，包括分子生物学，微生物学，生物技术，基因组学，流行病学，生物化学和医学。2009年起为理文编辑工作。

Dr Fox completed a PhD in microbiology at the University of Oxford, investigating novel phase variable LPS biosynthetic genes in Haemophilus influenzae. She then spent five years as a post-doctoral researcher at the University of Queensland, Australia, focusing on the role of DNA methyltransferases in gene regulation in bacterial pathogens. Other projects included the design and development of live, attenuated vaccines for veterinary pathogens. She has many first-author publications in high-ranking journals in the area of microbial pathogenesis. Dr Fox is now a full-time editor, with extensive editing experience in a broad range of biological disciplines including molecular biology, microbiology, biotechnology, genomics, epidemiology, biochemistry and medicine. Dr Fox began editing with the Edanz Group in 2009.

Dr Morris拥有肿瘤学（特别是放射生物学、放射线疗法、化学疗法）专业背景。曾在牛津大学作为科研人员和首席研究员，研究癌症新药和新式放疗法的开发。近期作为医学作者和科研员，从事于生物技术的研究和著书。涉及的诊疗领域包括肿瘤、传染病、增龄性黄斑变性和肥胖。曾作为访问学者在美国Brookhaven国家实验室工作。曾在同行审查期刊杂志发表50多篇文章及专书论文。2009年开始为理文编辑工作。

Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.

Featured Editor

Currently a post-doctoral research fellow at the Institute of Immunology at the Ludwig Maximilian University, Munich, Germany

德国慕尼黑Ludwig Maximilian大学免疫学研究所博士后研究生，博士研究课题是“关于B细胞异性抗原反应的定量分析”，目前主要专注于树突状细胞约束抗原递呈后T细胞的反应研究。在淋巴细胞生物学以及细胞群动力学、寄生虫学和抗体工程的建模方面，拥有大量研究经验。 另外还有流式细胞术、转基因鼠模型和标准免疫学和分子生物技术实验室经验。曾三度以第一作者的身份，在同行审查的期刊杂志上发表论文，另以共同作者身份发表了四篇文章。德语读写流利。他的第二外语学历，极大增强了他对非母语人士所用语言的用法理解。熟悉稿件撰写与编辑的不同阶段工作，与期刊杂志编辑和审稿人保持着良好的人脉关系。2010年开始为理文编辑工作，担任编辑一职。

Dr Turner is a post-doctoral research fellow at the Institute of Immunology at the Ludwig Maximilian University, Munich, Germany. Her PhD thesis was entitled “A quantitative analysis of B cell responses to specific antigen” and her current work is focused on T cell responses following dendritic cell-restricted antigen presentation. Dr Turner has extensive research experience in lymphocyte biology and in the modeling of cellular population kinetics, parasitology and antibody engineering. She has laboratory expertise in flow cytometry, transgenic mouse models and standard immunological and molecular biological techniques. Dr Turner has published three first author peer-reviewed journal articles and is a co-author on another four. Dr Turner is fluent in written and spoken German. Her second-language study has given her a greatly enhanced understanding of the language usage and grammar of non-native speakers and writers. She is familiar with all stages of the manuscript preparation and editing process and with correspondence with journal editors and reviewers. Dr Turner began working with the Edanz Group as an editor in 2010.

Featured Editor

Neurodegenerative disease expert with more than 32 peer reviewed publications

Dr Bijur的研究领域是神经退行性疾病（如老年痴呆症和帕金森氏病）和脑代谢功能。在精神病学和肿瘤形成与癌变领域拥有丰富经验，包括精神分裂症、双相情感障碍、代谢紊乱（如糖尿病）等。对细胞培养技术、分子生物学技术和啮齿类动物模型有透彻的理解。他的个人研究一直由美国国立卫生研究院和精神分裂症与抑郁国家研究联盟提供资助。已撰写32篇同行评审出版物，出席了大量科技学术会议，包括神经科学协会和美国癌症研究协会会议。还担任了多家生物医学期刊杂志和基金发放机构的审稿人。 2010年加盟理文编辑，担任撰搞人和编辑。

Dr Bijur's work is on neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and investigations into brain metabolic functions. Dr Bijur has extensive experience in the areas of psychiatry, including schizophrenia and bipolar disorder, metabolic disorders such as diabetes, and in oncogenesis and carcinogenesis. He has thorough understandings of cell culture techniques, molecular biology techniques, and rodent animal models. His personal research has been funded by the U.S. National Institutes of Health and the National Alliance for Research on Schizophrenia and Depression. Dr Bijur has authored over 32 peer-reviewed publications, and has presented at numerous scientific conferences including the Society for Neuroscience and the American Association for Cancer Research, among others. He also serves as a reviewer for several biomedical journals and granting agencies. Dr Bijur joined the Edanz Group as an editor and medical writer in 2010.

Dr Colebrooke的博士研究课题是“帕金森多巴胺大鼠模型的分子、神经生化和行为分析”。之后成为英国Babraham Institute分子神经科学实验室博士后研究员。熟悉各种常用实验室技术、试验和小动物模型。曾多次以第一作者身份在国际期刊杂志上发表文章。2006年开始为理文编辑工作，任编辑一职。

Dr Colebrooke’s PhD title was “Molecular, neurochemical and behavioural analyses of a novel dopamine-depleted mouse model of Parkinson’s disease.” She then was a post-doc research scientist in the Laboratory of Molecular Neuroscience, The Babraham Institute, UK. Dr Colebrooke is familiar with all the usual laboratory techniques and tests, along with small animal models. Dr Colebrooke has several first-authored publications in international journals. She began as an editor with Edanz Editing in 2006.

Featured Editor

Expert in molecular virology and biology

Dr Burkala目前任职于奥克拉荷马大学微生物学和免疫学系。拥有病毒学和分子生物学的多年经验，最近主攻艾滋病毒免疫与进化。除对大量出版文章和基金申请书进行审稿外，还对大量专业科技文章进行了同行评审，包括癌症生物学和免疫学领域。专业技术领域包括：先进的分子生物学技术（如：异源双链追踪分析和质谱分析）；免疫技术（如：流式细胞术），ELISA法，免疫印迹法和酶联免疫斑点免疫学技术，细胞培养技术（包括初代细胞和细胞株培养、病毒培养与提纯、细胞体外迁移能力测定、共聚焦显微镜技术等），动物实验（鼠、羊、牛和兔子）等。

Dr Burkala is currently employed at the University of Oklahoma in the Department of Microbiology and Immunology. Dr Burkala has many years of experience in molecular virology and biology, and has recently specialized in HIV immunology and evolution. He has peer-reviewed publications in a broad range of scientific areas including cancer biology and immunology in addition to reviewing many publications and grant applications. Dr Burkala’s technical skills include: cutting-edge molecular biological techniques such as heteroduplex tracking assays and mass spectrometry, common techniques like cloning, PCR, real-time PCR and recombinant protein purification, immunological techniques such as flow cytometry, ELISA, Western immunoblot and ELISPOT, cell culture techniques including primary and cell line culture, virus culture and purification, transwell migration assays and confocal microscopy, and live animal experiments including the use of mice, sheep, cattle, and rabbits for immunizations and immunological analyses.

Dr Roth发表的文章涉及以下领域：T细胞生物学、基因重排的分子机制、发育生物学、神经生物学、核受体生物学。在转基因动物模型、开发基因组和蛋白质组技术、运用基因和蛋白质表达谱方法进行疾病诊断和治疗（包括糖尿病、肥胖、血液疾病和肿瘤）等方面拥有丰富经验。联合撰写并在影响力极高的杂志上发表了13篇文章，同时还和专利发明人联合撰写了5篇专利书。曾为知名生物制药、医疗设备和生物科技等公司提供有关平台技术和产品开发方面的顾问建议。多年担任昆尼皮亚克大学客座教授，在线授课生物学本科课程。在美国西北大学期间，获美国癌症学会博士后奖学金；在纽约冷泉港期间，研究发育神经生物学。于2010年开始为理文编辑工作，担任编辑。

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr. Creasey 是爱丁堡大学Dr. Paul Hunt实验室的高级博士后研究人员，该实验室致力于啮齿动物疟疾模型青蒿素抗药性的遗传学研究。Dr. Creasey 一直专注于热带病学和热带寄生虫疾病，以及流行病学的研究。凭借着在血清学和微生物学领域的研究经验，她曾在非洲当地开展过多次抗寄生虫的药物试验。而后在爱丁堡开始了遗传学和分子生物学的研究。Dr. Creasey擅长使用清晰明确的语言传达出学术内容，在她的职业生涯中，曾为来自中国、泰国、斯里兰卡、沙特阿拉伯以及大部分非洲国家的作者编辑过大量的期刊文章和博士论文。Dr. Creasey 从2007年起加入理文编辑。

Dr Creasey is a senior post-doctoral fellow in the laboratory of Dr Paul Hunt, University of Edinburgh (genetics of artemisinin drug resistance in a rodent malaria model). Her special interests have been in the field of tropical medicine and tropical parasitic diseases, with training in the epidemiological aspects of disease. Her field experience in serology and microbiology involved a number of anti-parasitic drug trials in Africa. Later in Edinburgh, genetics and molecular biology were focused on. Dr Creasey has the ability to communicate science in clear, unambiguous language. During her career she has edited journal articles and PhD theses for scientists from China, Thailand, Sri Lanka, Saudi Arabia, and most African countries. Dr Creasey joined Edanz Editing as an editor in 2007.

Dr Sheen目前为圣迭戈州立大学博士后研究员，从事微生物致病的研究。工作内容包括微生物生境和血脑屏障渗透。她拥有MRSA感染新药治疗方法的两项开发专利。于新西兰皇家农业研究所（新西兰林肯郡）完成博士研究，研究重点是运用基因技术改良微生物生物防治剂的生存土壤。其它研究包括：南极抗冻鱼系统发育分析和物种进化研究。从2011年起在理文编辑担任编辑工作。

Dr Sheen is a postdoctoral research fellow at San Diego State University, studying microbial pathogenesis. Her work encompasses microbial niche establishment as well as penetration of the blood-brain barrier. She also has two patents for the development of novel therapeutic agents for treatment of MRSA infections. Dr Sheen carried out her PhD research at AgResearch in Lincoln, New Zealand, focusing on applying genetic techniques to improve the soil survival of a microbial biocontrol agent. Her other research has involved the phylogenetic analysis of Antarctic notothenioid fish and species evolution. Dr Sheen began editing for Edanz Editing in 2011.

Dr Leslie曾从事过生物化学和分子生物学研究，主要从事癌症、老化和病毒性疾病的分子生物学研究。2000年，在“日本科学与技术”基金的资助下，于神奈川县癌症研究中心研究所进行干细胞研究。次年，在东京大学进行抗癌化合物研究。随后3年内，在日本理化学研究所从事蛋白质产生与分析。2006年进入制药公司担任协调人和医学撰稿人；2010年加盟理文编辑，任撰稿人和编辑。

Dr Leslie Bestilny’s PhD was in biochemistry and molecular biology. His research focused on the molecular biology of cancer, aging and viral diseases. In 2000 he received a Japan Science and Technology (STA) scholarship to research stem cells at the Kanagawa Cancer Research Center Institute. The following year he performed research of anti-cancer compounds at The University of Tokyo. This was followed by 3 years of protein production and analysis at RIKEN Institute. He joined Pharma Inc. in 2006 as a coordinator and medical writer, and in 2010 began working with the Edanz Group as a writer and editor.

英国爱丁堡大学药理学研究员、伦敦大学和牛津大学研究助理、阿伯丁大学生理学讲师。在阿伯丁大学，她还建立了电生理实验室，用以研究药物作用与哺乳动物心室肌细胞电活动的关系。Dr Cant拥有丰富的写作和编辑经验，曾为欧共体Cordis Results and Publications数据库和BEST（英国科技专家）数据库及其在美国的姐妹数据库编辑生物和物理科学类文章。多年任Thomson Scientific医学编辑、数据库编索人，拥有心血管病学、肠胃病学、神经科学、流行病学、药理学和生理学领域的知识背景。

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

原就读格拉斯哥大学微生物学，后去阿伯丁大学疱疹病毒学攻读博士学位。之尔后主攻电子显微镜，又继续了几年超声波治疗癌症的博士后研究，后来又取得信息学文凭，自1991年起从事医疗与药品信息工作。曾为EMBase和几家医药数据库担任文摘；多家期刊杂志（其中包括Lancet Infections Diseases and Lancet Oncology）新闻撰稿人；任Springer和Society for General Microbiology编辑。除编辑工作外，还帮助数家知名药业公司建立产品文献数据库。2005年加盟理文编辑，主要编辑医学和生命科学方面文章，尤其是微生物学和传染病学。是普通微生物学会会员。

Dr Kerr originally studied microbiology at Glasgow University and went on to complete a PhD on herpes viruses at Aberdeen University. He then specialized in electron microscopy and continued for a few years in post-doctoral research on ultrasound treatment of cancer. This was followed by a diploma in information studies, and he has worked in medical and drug information since 1991. Dr Kerr has worked previously as an indexer for EMBase and other pharmaceutical databases, a news writer for several journals including Lancet Infections Diseases and Lancet Oncology, and as a copyeditor for Springer and the Society for General Microbiology. In addition to editing, he works on product literature databases for a number of leading pharmaceutical companies. Dr Kerr joined the Edanz Group in 2005 and edits in the medical and life sciences, with a particular interest in microbiology and infectious diseases. He is a member of the Society for General Microbiology.

Brunker 女士具有二十余年生物医学领域稿件的编辑经验，包括向同行评审期刊投稿的文章、学位论文和学术文章、向美国监管机构（食品和药品管理局以及美国专利商标局）递交的申请材料；各种药物广告、网站内容、演讲稿、论文以及会议等场合所需的材料；同时还包括广泛的医学教学资料。她的硕士学位论文探讨了HIV+ CD4+ 细胞的凋亡。还曾参与过乳癌和环境医学的实验室工作。

Ms Brunker has been editing biomedical documents for over two decades, including submissions to peer-reviewed journals, dissertations and other academic papers, applications to US regulatory agencies (the Food and Drug Administration and the Patent and Trademark Office), pharmaceutical advertisements of all types, Web site content, slide presentations, scripts and other support pieces for conferences and similar events, and a wide variety of medical education materials. Her master’s thesis was on apoptosis in HIV+ CD4+ cells. She has also done laboratory work in breast cancer and environmental medicine.

医学和科学编辑/撰稿人，拥有为医疗机构和药品广告研究机构进行生命科学内容开发的经验。最初任加拿大蒙特利尔戴维斯夫人医学研究院癌症研究实验室研究助理，进行分子和细胞生物学实验，内容包括：mRNA、DNA和蛋白质提纯、Northern 和Western杂交、RT - PCR、细胞运输、原代组织培养、各种药物疗效研究。还撰写了期刊杂志的投稿和向资助机构提供的实验室文件。后又从事医药广告工作8年，负责校对、审稿和事实审查；撰写了医学教育计划（向医师和护理人员传授药品标签方面的知识）。同时还是经验丰富的医学与科学自由撰稿人和编辑，为各种研究实验室和企业实体供稿。于2009年开始为理文编辑工作，担任编辑。

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

Dr Rogers目前任瑞士日内瓦大学科学交流与写作讲师，此前曾任生物技术行业的一个研究实验室主任一职，专门从事蛋白质组学研究，同时还从事食品行业内的初级材料研究。在巴黎大学从事博士后研究，并作为皇家学会研究员在苏塞克斯大学从事研究。发表的文章内容广泛，是七份生物技术专利的联合撰稿人。于2010年开始在理文担任编辑。

Dr Rogers presently is a lecturer in scientific communication and writing at the University of Geneva, Switzerland. He has previously held research positions as a laboratory head within the biotechnology industry, specializing in proteomics research, and within the food industry, conducting research in primary materials. He completed post-doctoral research within the University of Paris, as a Royal Society Fellow, and at the University of Sussex. He has published widely and is joint author to seven biotechnology patents. Dr Rogers began working as an editor for the Edanz Group in 2010.

博士论文的内容是利用原代颗粒细胞培养来监测凋亡性损伤后（兴奋性毒性、氧化应激和营养缺乏）线粒体功能的变化和细胞动态平衡。该项目研究了对一系列损伤的神经元细胞反应，重点研究凋亡路径上下游凋亡蛋白的激活和补充。出生于澳大利亚，目前在Florey Neuroscience Institutes神经肽实验室从事博士后研究，监测胎儿发育期的神经形成、确定记忆形成的信号途径。目前正在参与一项缺血性损伤体内体外模型的神经保护研究。自2009年起为理文编辑工作，担任编辑。

Dr Diwakarla’s PhD thesis involved the use of primary cerebellar granule cell cultures to monitor changes in mitochondrial function and cellular homeostasis after apoptotic injury (excitotoxicity, oxidative stress and trophic factor withdrawal). Her project examined the cellular responses of neurons to a range of insults focusing largely on the activation/recruitment of apoptotic proteins involved both upstream and downstream of the apoptotic pathway. Currently, Dr Diwakarla, who was born in Australia, is a post-doctoral scientist in the Neuropeptides Laboratory at the Florey Neuroscience Institutes were she is monitoring neurogenesis during fetal development and determining the signaling pathways involved in memory formation. She is also contributing to the investigation of neuroprotection in in vitro and in vivo models of ischemic damage. She began working as an editor with the Edanz Group in 2009.

Pishief先生，出庭大律师、法律编辑和撰稿人，曾编写过很多文字书籍、法律公告，并为多家全球法律平台撰写在线稿件。Pishief先生既拥有法律背景，又拥有科学知识，他在生物医学科学领域的研究重点是分子病理学，尤其是大脑、心脏、肝、肾、骨骼、血液、淋巴系统的病理学（包括组织学）；基因（包括测序、生物信息学和遗传病）；生物医学实验室技术（重点是DNA/ RNA的提取与隔离、反转录、PCR技术和凝胶电泳）；代谢；免疫学；医学微生物学和生理学（包括神经生理学和神经影像学）。是一位经验丰富的报告与摘要写手。2011年起加入理文编辑。

Mr Pishief, a barrister and solicitor, is a legal editor and writer of manuscripts for publication in text books, legal bulletins, and online on global legal platforms. His background in both law and science, with his biomedical science study focusing on molecular pathology, specifcally pathology (including histology) of the brain, heart, liver, kidney, bone, blood, and lymphoid system; genetics, including sequencing, bioinformatics and genetic disorders; biomedical laboratory techniques, with a focus on DNA/RNA extraction and isolation, reverse transcription, PCR, and gel electrophoresis; metabolism; immunology; medical microbiology; and physiology (including neurophysiology and neuroimaging). An experienced report and abstract writer, Mr Pishief joined the Edanz Group as an editor in 2011.

分子病毒学家，专注于动物保健。在皇家兽医学院攻读兽医病毒学博士学位时的研究课题是，“牛病毒性腹泻病毒的遗传变异和细胞嗜性”。Dr Desport在莫道克大学完成的博士后研究课题是：重组蛋白疫苗的培育和试验，以控制巴里牛患Jembrana的病情。掌握的技能和方法包括：病毒细胞培养和净化；实时RT/PCR；克隆；DNA排序与分析；DNA/RNA提取与操作；重组蛋白在原核生物系统中的表现和净化；ELISA的培育和优化；原位杂交；抑制免疫；组织病理学和肽地图绘制。曾以第一作者身份发表8篇期刊文章，多次出席国家级和国际级学术会议。现为多家国际期刊的受邀评审员，最近曾为“慢病毒和巨噬细胞：分子和细胞相互作用”一书担任编辑。2011年加盟理文，担任编辑。

Dr Desport is a molecular virologist with interests in animal health. Her thesis for her PhD in Veterinary Virology from the Royal Veterinary College was entitled “Genomic Variation and Cell Tropism of Bovine Viral Diarrhea Virus”. Dr Desport post-doctoral position at Murdoch University focused on the development and testing of a recombinant protein vaccine to control Jembrana disease in Bali cattle. Skills and techniques include cell culture and purification of viruses; Real-Time RT/PCR; cloning; DNA sequencing and analysis; DNA/RNA manipulation and isolation; expression and purification of recombinant proteins in prokaryotic systems; development and optimization of ELISAs; in situ hybridization; immunostaining; histopathology and peptide mapping. Dr Desport has published eight first-author journal articles and has presented at several national and international conferences. She is an invited reviewer for a number of international journals and has recently edited a book entitled “Lentiviruses and Macrophages: Molecular and Cellular Interactions”. Dr Desport joined the Edanz Group as an editor in 2011.

美国堪萨斯州曼哈顿岛堪萨斯州立大学知名名誉退休教授。在眼睛细胞生物和蛋白质化学领域拥有丰富经验，从事相关研究长达30余年。其研究长期以来得到了美国国立卫生研究院的资金支持。一直为多个国家和国际委员会从事视觉研究，其中包括国家眼科研究所科学顾问委员会、Lens & Cataract Panel of the National Eye Institute、视觉与眼科学研究理事委员会等。Takemoto教授出生于美国，祖籍日本，曾作为日本学术振兴会研究员广泛开展研究和考察活动。在同行评审期刊上发表了150余篇作品，于2011年加入理文，担任编辑。

Prof Takemoto is a University Distinguished Professor Emeritus at Kansas State University, Manhattan, KS, USA. He has extensive experience in the cell biology and protein chemistry of the eye, which he has studied for over 30 years. His research has been continuously funded by the National Institutes of Health of the US. He has served on numerous national and international boards dealing with vision research, including the Board of Scientific Counselors of the National Eye Institute, Lens & Cataract Panel of the National Eye Institute, and the Board of Directors of the Association for Research in Vision & Ophthalmology (ARVO). Prof Takemoto, though US-born, traces his ancestry back to Japan and has conducted research and traveled extensively in Japan as a Fellow of the Japan Society for the Promotion of Science. He has published over 150 peer-reviewed manuscripts, and joined the Edanz Group as an editor in 2011.

Dr Davy的博士论文题目是“Characterisation of White Patch Syndrome, a putative disease affecting corals in the genus Porites on the Great Barrier Reef”。在珊瑚礁生态（包括珊瑚白化和珊瑚疾病）研究方面经验丰富。此外还涉足海洋病毒学、海洋生态保护、岩岸生态以及海洋应用科学（包括渔业资源评估和海防）等领域的研究。在分子领域，Dr Davy一直在从事引物设计和序列分析、DNA抽提、荧光原位杂交和各种类型的凝胶电脉，包括变性梯度凝胶电泳（DGGE）、脉冲场凝胶电泳（PFGE）和单链构象多态性（SSCP）、组织病理学、透射电镜和共聚焦显微术等方面的研究。曾在同行评审期刊上发表12篇论文，多次出席国家级和国际级会议。此外，Dr Davy还获得了创意写作硕士学位，她的一本非小说类书籍于2011年由兰登出版社新西兰分社出版。现为自由撰稿人和编辑，学术顾问。自2011年起开始为理文编辑工作。

Dr Davy’s PhD thesis was entitled “Characterisation of White Patch Syndrome, a putative disease affecting corals in the genus Porites on the Great Barrier Reef”. She has extensive experience of the ecology of coral reefs, including bleaching and coral disease. Her expertise also extends to the areas of marine virology, marine conservation, rocky shore ecology, and areas of applied marine science, including fish stock assessment and coastal defenses. In molecular fields, Dr Davy has undertaken primer design and sequence analysis, DNA extraction, fluorescent in situ hybridization and various types of gel electrophoresis, including DGGE, PFGE and SSCP, histopathology, transmission electron microscopy and confocal microscopy. Dr Davy has published 12 papers in peer-reviewed journals and presented at several national and international conferences. Dr Davy has also completed an MA in Creative Writing and had a non-fiction book published by Random House New Zealand in 2011. Dr Davy is presently a freelance writer and editor, and scientific consultant. She began working with the Edanz Group as an editor in 2011.

Featured Editor

Expert in models and diagnosis of Parkinson's disease

Tinsley拥有南澳弗林得斯大学医学院博士学位。研究课题为“非病毒神经胶质细胞传染：中枢神经系统再生治疗战略”。博士后工作期间，在首位证明成年人大脑中神经形成的专家Peter Eriksson教授的神经干细胞实验室工作。之后重返澳大利亚，在霍华德•弗利研究所工作，研究帕金森氏疾病的模型和诊断。拥有十多年医学研究经验，曾在知名专业期刊发表作品，包括Annals of Neurology。2011年起为理文编辑工作，担任编辑。

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011.

Hendry教授的主要研究领域包括RNA昆虫病毒的分子生物学。此外，曾在南非格雷厄姆斯敦的罗德斯大学从事教学工作，教授病毒学、分子生物学和免疫学课程。拥有广泛的国际研究经验，曾是美国威斯康辛大学麦迪逊分校、台湾台中国立中兴大学、美国加州大学戴维斯分校和澳大利亚堪培拉联邦科工组织的访问学者。担任了10年的国际病毒分类委员会（ICTV）委员，同时还是美国微生物学会（ASM）、英国普通微生物学会（SGM）和国际无脊椎动物病理学会（SIP）会员。从事了7年的南非国家研究基金会研究拨款申请审查工作。曾在国际期刊上发表25篇论文，出席各种国际大会，并为多家期刊评审稿件。2011年加盟理文，担任编辑。

Prof Hendry main research was in the molecular biology of RNA insect viruses. He also taught virology, molecular biology and immunology at Rhodes University in Grahamstown, South Africa. Prof Hendry has wide international research experience, having been a Visiting Scientist at the University of Madison – Wisconsin, USA, at National Chung Hsing University in Taichung, Taiwan, at the University of California – Davis, USA, and at the CSIRO in Canberra, Australia. He was an appointee to the International Committee on the Taxonomy of Viruses (ICTV) for 10 years, and was a member of the American Society for Microbiology (ASM), the Society for General Microbiology (SGM), UK, and the Society for Invertebrate Pathology (SIP), USA. He spent seven years as a referee for research grant applications sent to the National Research Foundation (NRF) of South Africa. Prof Hendry has published over 25 papers in international journals, has presented at numerous international congresses, and has served as referee for scientific manuscripts submitted to several journals. Prof Hendry joined the Edanz Group as an editor in 2011.

Dr J. Ludovic Croxford是一位多学科免疫学家，拥有多个领域的研究经验，尤其在神经免疫学、自体免疫和肿瘤学领域。博士期间的研究课题是证明细胞因子基因治疗在治疗动物模型自体免疫疾病中的应用可能性，博士后阶段主要针对诱发自体免疫疾病的病毒性分子模拟的机制进行研究。随后于日本东京国立神经和神经医疗研究中心下属国立神经学研究所对新型NKT细胞在多发性硬化模型中的作用进行研究。之后，从事白血病免疫性疾病肿瘤的抑制机制的研究。Dr Croxford曾在Nature、Nature Immunology和Nature Medicine等多种期刊杂志上发表40余篇同行评审论文、评论和专书论文。2011年12月加入理文编辑。

Dr J. Ludovic Croxford is a multi-disciplinary immunologist with research experience in a wide range of fields, especially neuroimmunology, autoimmunity and oncology. His PhD research demonstrated the potential use of cytokine gene therapy for the treatment of animal models of autoimmune disease, and his post-doctoral research focused on the mechanisms of viral molecular mimicry to induce autoimmunity. Dr Croxford next studied the role of a novel NKT cell in a multiple sclerosis model at the National Institute of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan. Following this he studied the mechanisms of immune-mediated tumor suppression for leukemia. Dr Croxford has published over 40 peer-reviewed papers, reviews and book chapters in journals including Nature, Nature Immunology and Nature Medicine. Dr Croxford joined the Edanz Group as an editor in December 2011.